INFINITI RVP Plus
-
The INFINITI Respiratory Viral Plus is CE Marked.
-
The INFINITI Respiratory Viral Plus is designed to detect 25 common respiratory viruses.
-
The INFINITI Respiratory Viral Plus utilizes the RVP Plus Intellipac, RVP Plus Amp Mix and the RVP Plus BioFilmChip Microarray.
-
The INFINITI Respiratory Viral Plus is automated by the INFINITI Analyzer.
-
Influenza: A/Swine H1N1 and B
-
Human Parainfluenza Virus (HPIV): 1, 2, 3, 4
-
Rhinovirus: A and B
-
Enterovirus: A, B, C, D
-
Coronavirus: HKU1, OC43, NL63, 229E
-
Human Metapneumovirus (HMPV): A and B
-
Human Respiratory Syncytial Virus (HRSV): A and B
-
Adenovirus: A, B, C, E
-
Simultaneous multiplexed determination of 25 respiratory viruses including subtypes
-
Rapid turnaround time enhances workflow efficiency
-
Load & Go automated on the INFINITI/INFINITI PLUS Analyzer.
-
Replicate determinations on a single BioFilmChip Microarray ensures quality results
- Uses nasopharyngeal aspirates (NPA).
- Requires 4 ul of purified RNA/reaction.
- Respiratory Virus symptoms can vary from annoying colds to life-threatening respiratory failure.
- Only 28% of hospitalizations and 17% of children with laboratory-confirmed influenza infections were diagnosed as actually having influenza.
- Rapid respiratory virus diagnosis of inpatients can lead to benefits in several areas: up to 50% reduction in hospital days, 30% reduction in antibiotic use, and 20% reduction in unnecessary diagnostic tests and procedures.
- Will allow:
- public health labs to track multiple viruses with 1 sampling
- monitoring of viral subtypes in the populace
- easy integration to existing workflows
- K.A. Poehling, et.al., The Underrecognized Burden of Influenza in Young Children NEJM, 2006;355:31-40.
- CDC: Disease Surveillance
- Hendrickson, K. J. 2005. Cost-effective use of rapid diagnostic
techniques in the treatment and prevention of viral respiratory infections. Pediatr Ann 34(1) 24-31.